Carboprost 250 mcg Overview & Research Applications Carboprost 250 mcg is a synthetic analogue of prostaglandin F2α widely used in controlled clinical and research-based medical settings. It is primarily studied and administered for its strong uterotonic properties, making it effective in managing postpartum haemorrhage caused by uterine atony and in medically indicated second-trimester pregnancy termination. By stimulating sustained uterine contractions, Carboprost 250 mcg plays a critical role in emergency obstetric care when first-line treatments are insufficient. This formulation is intended strictly for supervised medical use and is handled within regulated healthcare environments to ensure patient safety and therapeutic accuracy. Active Ingredients in Carboprost 250 mcg Carboprost 250 mcg contains carboprost tromethamine as its sole active ingredient. Each ampoule is formulated as a sterile intramuscular injectable solution delivering a precise 250 microgram dose. The solution is typically clear to slightly yellow in appearance and is manufactured to meet strict pharmaceutical quality standards for clinical administration. Research Use & Intended Applications Carboprost 250 mcg is extensively researched and utilized in obstetric and gynecological care. Its primary applications include the treatment of severe postpartum haemorrhage when uterine atony does not respond to conventional uterotonics such as oxytocin or ergometrine. It is also used in therapeutic abortion protocols during the second trimester under appropriate medical supervision. In research contexts, carboprost continues to be evaluated for its effectiveness, safety profile, and optimal dosing strategies in emergency obstetric interventions. Safety & Handling Considerations Carboprost 250 mcg must be administered only by trained healthcare professionals in hospital or clinical environments equipped to manage potential complications. Continuous patient monitoring is essential during administration due to the possibility of systemic side effects and uterine hyperstimulation. Common reactions may include nausea, vomiting, diarrhoea, fever, flushing, and abdominal cramping. These effects are generally transient but require clinical observation to ensure patient stability. Who Should Avoid Using Carboprost 250 mcg Carboprost 250 mcg is contraindicated in patients with known hypersensitivity to prostaglandins. It should not be used in individuals with severe asthma due to the risk of bronchospasm. Patients with active pelvic infections, significant cardiovascular disease, or severe hepatic or renal impairment should also avoid its use unless the benefits clearly outweigh the risks and are assessed by a qualified clinician. Dosage Guidelines for Carboprost 250 mcg For postpartum haemorrhage, the usual initial dose is 250 mcg administered intramuscularly. Additional doses may be given at intervals ranging from 15 to 90 minutes if clinically necessary. The total cumulative dose should not exceed 2 mg. For therapeutic abortion, dosing schedules vary based on gestational age, patient condition, and clinical judgment. All dosing must follow established medical protocols and be determined by the supervising physician. Storage & Handling Carboprost 250 mcg should be stored in a refrigerator at temperatures between 2°C and 8°C. Protect the ampoules from light and do not freeze. Once opened, the solution should be used immediately, and any unused portion must be discarded in accordance with medical waste regulations. Quality Assurance & Authenticity Carboprost 250 mcg supplied through verified pharmaceutical channels is manufactured under stringent quality control standards to ensure potency, sterility, and consistency. Authentic products undergo rigorous inspection and compliance checks prior to clinical distribution. Frequently Asked Questions–Carboprost 250 mcg What is carboprost 250 mcg used for?Carboprost 250 mcg is used to manage severe postpartum haemorrhage due to uterine atony and for medically supervised second-trimester pregnancy termination. What is the maximum dosing of carboprost?The total cumulative dose should not exceed 2 mg, administered in divided intramuscular injections as clinically required. Why is carboprost not given in asthma?Carboprost may cause bronchoconstriction, which can trigger severe bronchospasm in patients with asthma, making it unsafe for use in such individuals. Is carboprost used to stop bleeding?Yes, carboprost is specifically used to control excessive postpartum bleeding by inducing strong uterine contractions that compress uterine blood vessels. Order with Confidence from Acute Pharmacy ® ™ Acute Pharmacy ® ™ provides Carboprost 250 mcg sourced through regulated supply chains, ensuring product integrity and compliance with pharmaceutical standards. Orders are handled with discretion, accuracy, and a commitment to quality-focused healthcare support. Add to cart today for reliable research-grade quality you can trust.
